STOCK TITAN

Evaxion A/S (NASDAQ: EVAX) reports initial share and warrant holdings

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Evaxion A/S filed an initial Form 3 showing its direct ownership in EVAX securities. The filing lists 129,139 Ordinary Shares held directly, plus multiple series of warrants over additional Ordinary Shares with different exercise prices and long-dated expirations.

Examples include warrants over 36,765 Ordinary Shares at an exercise price of 0.7400 expiring on 21 December 2026, and warrants over 46,100 Ordinary Shares at an exercise price of 0.0590 expiring on 31 January 2030. Several other warrant positions run through 2031 and 2036, illustrating Evaxion A/S’s combined equity and derivative exposure.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Evaxion A/S

(Last)(First)(Middle)
DR. NEERGAARDS VEJ 5F

(Street)
HORSHOLMDK-2970

(City)(State)(Zip)

DENMARK

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026
3. Issuer Name and Ticker or Trading Symbol
Evaxion A/S [ EVAX ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares129,139D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Warrants(1)12/21/202312/21/2026Ordinary Shares36,765$0.74D
Warrants(2)01/31/202501/31/2030Ordinary Shares46,100$0.059D
Warrants01/01/2016(3)12/31/2036Ordinary Shares98,188$0.1D
Warrants01/01/201712/31/2036Ordinary Shares479,604$0.1D
Warrants01/01/201812/31/2036Ordinary Shares3,888$0.1D
Warrants01/01/2020(3)12/31/2031Ordinary Shares5,112$0.1D
Warrants01/01/2021(3)12/31/2031Ordinary Shares21,396$5.38D
Warrants01/01/2024(3)12/31/2031Ordinary Shares17,708$0.07D
Explanation of Responses:
1. Warrants pursuant to private placement that closed 12/21/2023.
2. Warrants pursuant to public offering that closed 1/31/2025.
3. Vesting is 1/12 per month over 21 months from the initial exercise date indicated.
Remarks:
Exhibit List - Exhibit 24.1 Power of Attorney. This initial holding statement has been made for Lars Staal Wegner using the Issuer's CIK codes to satisfy Form 3 filing requirements. An amendment will be filed for Mr. Wegner upon receipt of his CIK filer codes from the SEC.
/s/ Michael Baird, Attorney-in-Fact03/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Evaxion A/S’s Form 3 for EVAX disclose?

The Form 3 discloses Evaxion A/S’s initial beneficial ownership in EVAX. It shows 129,139 Ordinary Shares held directly and several warrant positions over additional Ordinary Shares, each with specified exercise prices and expiration dates, outlining the company’s combined share and warrant exposure.

How many EVAX Ordinary Shares does Evaxion A/S hold directly?

Evaxion A/S reports direct ownership of 129,139 Ordinary Shares. This equity position is separate from its various warrant holdings and represents the current number of underlying shares already owned, as opposed to those that could be acquired through future warrant exercises.

What warrant positions does Evaxion A/S report in its EVAX Form 3?

Evaxion A/S lists multiple warrant positions over Ordinary Shares, each with its own exercise price and expiration. Examples include 36,765 underlying shares at 0.7400 per share and 46,100 underlying shares at 0.0590 per share, plus several additional series extending out to 2036.

When do Evaxion A/S’s EVAX warrants expire?

The warrants disclosed have staggered expiration dates, ranging from 21 December 2026 to 31 December 2036. This spread creates a long-dated derivative profile, allowing potential future share acquisition over many years if the warrants are exercised under their stated terms.

What is the significance of the warrant footnotes in Evaxion A/S’s Form 3?

Footnotes explain that some warrants arose from a private placement that closed on 21 December 2023 and a public offering that closed on 31 January 2025. Another note describes vesting of certain warrants at one-twelfth per month over 21 months from the indicated initial exercise date.

Does Evaxion A/S’s Form 3 show recent EVAX share purchases or sales?

The Form 3 records holdings rather than explicit purchase or sale transactions. All listed entries are characterized as holdings, with transaction codes not indicating open-market buying or selling, so the disclosure focuses on positions outstanding instead of recent trading activity.
Evaxion AS

NASDAQ:EVAX

View EVAX Stock Overview

EVAX Rankings

EVAX Latest News

EVAX Latest SEC Filings

EVAX Stock Data

29.94M
6.88M
Biotechnology
Healthcare
Link
Denmark
Horsholm